SCLN
Sciclone Pharmaceuticals Inc
SCLN
SCLN
Delisted
SCLN was delisted on the 13th of October, 2017.
136 hedge funds and large institutions have $366M invested in Sciclone Pharmaceuticals Inc in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
55% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 20
Holders
136
Holding in Top 10
1
Calls
$25K
Puts
$1K
Top Buyers
| 1 | +$74.2M | |
| 2 | +$4.06M | |
| 3 | +$3.08M | |
| 4 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
+$2.7M |
| 5 |
GP
GLG Partners
London,
United Kingdom
|
+$2.6M |
Top Sellers
| 1 | -$5.43M | |
| 2 | -$3.6M | |
| 3 | -$2.72M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
-$2.18M |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$1.54M |